• Welcome Guest
  • View Cart
  • Phone (US): 703.778.3080
  • 0Shopping Cart
  • Market Reports
  • Market Research Subscriptions
    • Knowledge Center
  • Custom Market Research
    • Quantitative Market Research
    • Qualitative Market Research
    • RateMyProduct
  • Blog
  • Featured
    • Free Downloads
    • View Webinars On-Demand
    • The IVD Market in 2023: $130 Billion and Growing
    • The Point of Care Testing Market
    • Immunoassays
  • About Us
    • Contact
  • Search
  • Menu Menu
  • Biotechnology
    • Next Generation Sequencing
    • Proteomics
    • Biopharmaceuticals
    • Instrumentation & Equipment
    • Emerging Technologies
  • Pharmaceuticals
    • Vaccines
    • Drug Delivery
    • Over-the-Counter
    • Drug Discovery
    • Cancer Treatment
    • Manufacturing & Packaging
    • Prescription Drugs
  • Diagnostics
    • Molecular Assays
    • Point-of-Care
    • Immunoassays
    • Infectious Disease
    • Clinical Chemistry
    • Oncology & Hematology
    • Lab Testing Services
    • Medical Imaging
  • Healthcare
    • Information Technology
    • Facilities & Settings
    • Insurance & Managed Care
  • Medical Devices
    • Wound Care
    • Drug Delivery
    • Equipment
    • Surgical
  • Login
Awaiting product image

Filter your search

Search Report Keyword
Price
CATEGORIES
  • Biotechnology Market Research
  • cell and gene therapy
  • cell therapy
  • Diagnostics Market Research
  • gene therapy
  • Healthcare Information Technology
  • Healthcare Market Research
  • in vitro diagnostic
  • IVD
  • life sciences
  • Medical Devices Market Research
  • Molecular & Nucleic Acid Testing
  • Pharmaceuticals Market Research
  • Point-of-Care Diagnostics
  • sciences
  • vaccines

Knowledge Center Sidebar

Most Popular Research

  • Cell and Gene Therapy Business Outlook
  • The Worldwide Market for In Vitro Diagnostic Tests, 14th Edition
  • Clinical Diagnostics MasterFile
  • The Global Market for Medical Devices, 11th Edition
  • The World Market for Molecular Diagnostics Tests, 10th Edition
  • Remote Patient Monitoring and Telehealth Markets, 12th Edition

Advanced Drug Delivery Markets (Liposomes, Polymers and Monoclonal Antibodies)

$2,500.00 – $5,000.00

Clear
SKU: KLI2880493 Categories: Drug Delivery Market Reports, Pharmaceuticals Market Research Pages: 170
  • Description
  • Table of Contents
  • Latest reports

Description

Drug delivery is evolving at a rapid rate with new drug product formulations being discovered frequently. Advanced drug delivery deals with developing solutions for new entities in therapeutic pharmacology such as protein and peptides and other novel compounds targeting drugs to specific disease sites including gene therapy. Treatments for chronic conditions and growth in patient-administered drugs are factors leading to greater focus on ease-of-use and convenience.

Advanced Drug Delivery Markets (Liposomes, Polymers and Monoclonal Antibodies) details the types of drug delivery systems, technologies and products utilizing advanced drug delivery systems The report describes the industry, its relationship to various healthcare channels, and the trends for the future.

The advanced drug delivery market is two-fold. First of all it identifies drug delivery technology Secondly, it identifies products in the pharmaceutical arena that utilize those drug delivery technologies. Because drug delivery technology is an integral part of sales of pharmaceuticals and drug delivery technology cannot exist without pharmaceuticals, revenues have been reported that include pharmaceutical sales. This report will provide market data that includes the pharmaceutical revenues of those products that utilize advanced drug delivery.

In this report, the advanced drug delivery market is divided into three main segments and market estimates are provided for indications within each category:


  • Liposome Drug Delivery
    (by Indication – Fungal Infections Cancer, Others)
  • Polymer Drug Delivery (by Indication – Cancer, Neutropenia, Hepatitis, Contraception, Schizophrenia, Acromegaly and Others)
  • Monoclonal Antibodies Drug Delivery (by Indication – Arthritis, Cancer, Multiple Sclerosis, Macular Degeneration, Respiratory Syncytial Virus, Others)

The following types of polymer delivery drugs are segmented within this report.

  • PEGylated Delivery
  • Emulsuion Delivery
  • Injectable Delivery
  • Nanoparticle Delivery
  • Others

A wide range of trends and issues that will impact the advance drug delivery market are discussed in the report including the current state of biotechnolgy expansion, molecular imprinted polymers, hot-melt extrusion, metallofullerenes, nanotechnology advancements and other emerging Drug Delivery technologies not yet on the market.

The following companies are profiled in the report:

  • Alkermes, Inc.
  • ALZA Corporation
  • AP Pharma
  • Centocor Ortho Biotech, Inc.
  • Eisai , Inc
  • Elan Corporation, Plc
  • EnColl Corporation, Inc.
  • Enzon Pharmaceuticals, Inc
  • Gilead Sciences, Inc.
  • Nektar Therapeutics
  • PDL BioPharma
  • pSivida Corp
  • SurModics, Inc
  • Tolmar, Inc

The research conducted by Kalorama Information included comprehensive research of primary and secondary sources such as interviews with company executives, company literature, databases, investment reports, and medical and business journals. New technologies, market developments, and research and development trends and expenditures were identified through patent and data-based searches, as well as via interviews with key personnel. Person-to-person and telephone interviews were the primary method of gathering information. E-mail correspondence was also used in the interview process. Interviews with 24 key industry officials, trade association spokespersons, consultants, healthcare providers, and government personnel were compiled to form the primary basis of information – particularly revenue and market share data- presented in this report.

All market data pertains to the worldwide market at the manufacturers’ level and was measured in U.S. dollars. The base year for data was 2010. Historical data are provided for 2006 through 2009, with forecast data provided for 2010 through 2014. Compound annual growth rates (CAGR) are provided for the 2006-2010, 2010-2014 and 2006-2014.

All Kalorama reports advertise the single user price. Use is limited to one user. We also feature department and global pricing for reports that we be utilized by more than one user at your company. Please consult ask your sales representative or select the correct license on our website.

For Kalorama’s take on the healthcare news of the week, based on our analysis of healthcare markets, follow Kalorama Information’s Key Point Blog at http://kaloramakeypoint.blogspot.com/

Table of Contents

CHAPTER ONE: EXECUTIVE SUMMARY

  • Overview
  • Market Drivers
  • Market Size and Growth
  • Market Trends

CHAPTER TWO: INTRODUCTION AND OVERVIEW

  • Introduction
  • Scope and Methodology
  • Reasons for Advanced Drug Delivery Systems
  • Phases of Drug Action

CHAPTER THREE: LIPOSOME DRUG DELIVERY

  • Overview
  • Liposome Targeting
  • Passive Targeting
  • Active Targeting
  • New Developments
  • Market Summary
  • Liposome Market by Indication
  • Liposome Market Competitive Analysis

CHAPTER FOUR: POLYMER DRUG DELIVERY

  • Overview
  • Polymeric Implants
  • Biodegradable Polymers
  • Nano- and Microparticulates
  • Polymer Micelles
  • PEGylation Technology
  • Hydrogel Polymers
  • Colloidal systems
  • PLA, PLG, and PLGA
  • Emulsions
  • Proteinaceous microparticles
  • New Developments
  • Market Summary
  • Market for Polymers by Product Type
  • Polymer Market by Indication
  • Polymer Market Competitive Analysis

CHAPTER FIVE: MONOCLONAL ANTIBODY DRUG DELIVERY

  • Overview
  • New Developments
  • Market Summary
  • Monoclonal Antibody Market by Indication
  • Monoclonal Antibody Market Competitive Analysis

CHAPTER SIX: TRENDS AND TECHNOLOGY DEVELOPMENTS

  • Expansion of Biotechnology
  • Incorporation of Technology
  • Molecular Imprinted Polymers
  • Antibiotic Biodegradable Implants
  • Hot-melt Extrusion Technology
  • Sorbent Technology
  • Gene Therapy Drug Delivery
  • Metallofullerenes
  • Antisense Delivery Systems
  • Nanotechnology advancements
  • Camouflaged Nanoparticles
  • Triggerable Drug Delivery
  • Prodrug Drug Delivery
  • Single Chain Antigen-Binding Protein Technology
  • Heat Shock Protein Technology
  • Other Emerging Drug Delivery Technologies

CHAPTER SEVEN: MARKET SIZE AND GROWTH

  • Total Market Summary
  • Geographical Market Growth Summary Competitive Growth Analysis

CHAPTER EIGHT: COMPANY PROFILES

  • Alkermes, Inc.
  • ALZA Corporation
  • AP Pharma
  • Centocor Ortho Biotech, Inc.
  • Eisai , Inc
  • Elan Corporation, Plc
  • EnColl Corporation, Inc.
  • Enzon Pharmaceuticals, Inc
  • Gilead Sciences, Inc.
  • Nektar Therapeutics
  • PDL BioPharma
  • pSivida Corp
  • SurModics, Inc
  • Tolmar, Inc

APPENDIX: COMPANY DIRECTORY

LIST OF EXHIBITS

CHAPTER ONE: EXECUTIVE SUMMARY

  • Table 1-1: The Global Market for Advanced Drug Delivery 2006-2014
  • Figure 1-1: The Global Market for Advanced Drug Delivery 2006-2014

CHAPTER TWO: INTRODUCTION AND OVERVIEW

  • Table 2-1: Sequence of Drug Action

CHAPTER THREE: LIPOSOME DRUG DELIVERY

  • Table 3-1: Marketed Liposome Drugs, as of October 2010
  • Table 3-2: New Developments in Liposome Drugs
  • Table 3-3: The Global Market for Liposomes 2006-2014
  • Figure 3-1: The Global Market for Liposomes 2006-2014
  • Table 3-4: The Global Market for Liposomes by Indication, 2006-2010
  • Figure 3-2: The Global Market for Liposomes by Indication, 2006-2010
  • Figure 3-3: Market for Liposomes by Indication 2006
  • Figure 3-4: Market for Liposomes by Indication 2010
  • Table 3-5: Advanced Drug Delivery: Liposome Market—Competitors Revenues and Market Shares 2009
  • Figure 3-5: Advanced Drug Delivery: Liposome Market—Competitor Market Shares 2009

CHAPTER FOUR: POLYMER DRUG DELIVERY

  • Table 4-1: Marketed Biodegradable Polymer Drugs, as of October 2010
  • Table 4-2: Marketed Nano- and Micro-particle Drugs, as of October 2010
  • Table 4-3: Marketed PEGylated Drugs, as of October 2010
  • Table 4-4: Marketed Hydrogel Polymer Drugs, as of October 2010
  • Table 4-5: Marketed Emulsions, as of October 2010
  • Table 4-6: New Developments in Polymers
  • Table 4-7: The Global Market for Polymers 2006-2014
  • Figure 4-1: The Global Market for Polymers 2006-2014
  • Table 4-8: Market for Polymers by Product Type 2006-2014
  • Figure 4-2: Market for Polymers by Product Type 2006-2014
  • Figure 4-3: Market for Polymers by Product Type 2010
  • Table 4-9: The Global Market for Polymers by Indication, 2006-2010
  • Figure 4-4: The Global Market for Polymers by Indication, 2006-2010
  • Figure 4-5: Market for Polymers by Indication 2006
  • Figure 4-6: Market for Polymers by Indication 2010
  • Table 4-10: Advanced Drug Delivery: Polymer Market—Competitors Revenues and Market Shares 2009
  • Figure 4-7: Advanced Drug Delivery: Polymer Market—Competitor Market Shares 2009

CHAPTER FIVE: MONOCLONAL ANTIBODY DRUG DELIVERY

  • Table 5-1: Key Marketed Monoclonal Antibodies, as of October 2010
  • Table 5-2: New Developments in Monoclonal Antibodies
  • Table 5-3: The Global Market for Monoclonal Antibodies 2006-2014
  • Figure 5-1: The Global Market for Monoclonal Antibodies 2006-2014
  • Table 5-4: The Global Market for Monoclonal Antibodies by Indication, 2006-2010
  • Figure 5-2: The Global Market for Monoclonal Antibodies by Indication, 2006-2010
  • Figure 5-3: Market for Monoclonal Antibodies by Indication 2006
  • Figure 5-4: Market for Monoclonal Antibodies by Indication 2010
  • Table 5-5: Advanced Drug Delivery: Monoclonal Antibody Market—Competitors Revenues and Market Shares 2009
  • Figure 5-5: 108 Advanced Drug Delivery: Monoclonal Antibody Market—Competitor Market Shares 2009

CHAPTER SIX: TRENDS AND TECHNOLOGY DEVELOPMENTS

  • Table 6-1: Nanotechnology Drug Delivery 2010, Companies and Technology

CHAPTER SEVEN: MARKET SIZE AND GROWTH

  • Table 7-1: The Worldwide Market for Advanced Drug Delivery Systems Revenues by Type 2006-2014
  • Figure 7-1: 1 The Worldwide Market for Advanced Drug Delivery Systems Revenues by Type 2006-2014
  • Table 7-2: The Worldwide Market for Advanced Drug Delivery Systems Market Share by Type 2006-2014
  • Figure 7-2: The Worldwide Market for Advanced Drug Delivery Systems Share by Type 2006
  • Figure 7-3: The Worldwide Market for Advanced Drug Delivery Systems
  • Share by Type 2010
  • Figure 7-4: The Worldwide Market for Advanced Drug Delivery Systems
  • Share by Type 2014
  • Table 7-3: Worldwide Advanced Drug Delivery by Geographical Region, 2006-2010
  • Figure 7-5: Worldwide Advanced Drug Delivery by Geographical Region, Sales by Region, 2006-2010
  • Figure 7-6: Worldwide Advanced Drug Delivery by Geographical Region, Percent Sales by Region 2006
  • Figure 7-7: Worldwide Advanced Drug Delivery by Geographical Region, Percent Sales by Region 2010
  • Table 7-4: Worldwide Market for Advanced Drug Delivery System Revenues and Market Share by Supplier 2009
  • Figure 7-8: Worldwide Market for Advanced Drug Delivery Systems Market Share by Leading Supplier 2009

 

    The Market for Needle-Free Drug Delivery Systems
    July 14, 2016
    Transdermal and Transmucosal Drug Delivery Markets: Forecasts to 2020
    November 25, 2015
    The World Market for Implantable and Needle-Free Drug Delivery Systems
    December 11, 2013
    The World Market for Transdermal Drug Delivery
    September 13, 2012

Related products

  • Placeholder image

    World Market for Anti-infectives Volume III: The World Market for Antiviral Medications, The

    $1,875.00 – $3,750.00
  • Placeholder image

    World Market for Anti-infectives Volume II: The World Market for Antibacterial Medications, The

    $2,500.00 – $5,000.00
  • Placeholder image

    Market for Rx-to-OTC Switches, 3rd Edition, The

    $2,625.00 – $5,250.00
  • Placeholder image

    Outsourcing in Drug Development – The Contract Research Market from Preclinical to Phase III

    $3,500.00 – $7,000.00

Contact Us

  • 671 North Glebe Road, Suite 1610 Arlington, VA 22203 United States

  • Email Us

  • 703-778-3080

  • Send us a message!

Pay Invoice

  • Pay an Invoice by Credit Card

Follow Us!

Latest Blogs

  • 4 Fascinating Facts About Cancer Diagnostics March 4, 2025
  • Food Animal Diagnostics Market: Spotlight on Disease Testing Amid Bird Flu Surge February 20, 2025
  • Custom Competitive Intelligence (CI) Research: A New Strategic Imperative For Lab Diagnostics Companies  February 19, 2025
  • The Rise of Pharmacodiagnostics in the $10 Billion Global Cancer Diagnostics Market February 1, 2025
  • IVD Trends to Watch: Personalized Medicine Adds Precision to Diagnostic Testing January 2, 2025

Sitemap

  • Home
  • About
  • Blog
  • Contact
  • Sitemap

Your Data and Privacy

  • View our Privacy Policy
  • GDPR Statement
  • Privacy Settings

About Us

Kalorama Information, part of Science and Medicine Group, has been a leading publisher of market research in medical markets, including the biotechnology, diagnostics, medical device, and pharmaceutical industries for more than 30 years. Our comprehensive, timely, quality research and innovative approach to analysis and presentation of market intelligence have made Kalorama Information a premier source of market information for top industry decision makers.

Visit Science and Medicine Group
European Vaccine Markets: Germany, UK, France, Spain, Italy, Rest of EuropeSample Preparation and Library Preparation for DNA Sequencers (Results of The...
Scroll to top